COVID-19 not stopping Indonesian giant Sido Muncul's expansion plans and production rates
Indonesia’s traditional herbal and pharma giant Sido Muncul's market expansion plans will continue despite the COVID-19 pandemic, with the firm revealing that its factory production is running at full force.
The company introduced seven new herbal and vitamin products to the market on Feb 20, and added that the sales of its flagship herbal product - Tolak Angin - had jumped amid the COVID-19 outbreak.
Coming in the form of soft capsules, the new products are Tolak Angin; Tolak Linu; Sari kunyit; vitamin E (100 I.U); vitamin E (300 I.U); vitamin D3 (400 I.U); and virgin coconut oil. Some of them, for example Tolak Angin and Tolak Linu, are already present in the market in other dosage forms, such as powder and sachets.
The herbal product, Tolak Angin, which mainly consisting of rice, fennel, Indian screw tree fruit, and clove, is designed to help with anti-bloating, flu, and dry throat.